Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 5—May 2025
Dispatch

Influenza A(H1N1)pdm09 Virus with Reduced Susceptibility to Baloxavir, Japan, 2024

Emi TakashitaComments to Author , Hiroko Morita, Shiho Nagata, Seiichiro Fujisaki, Hideka Miura, Tatsuya Ikeda, Kenichi Komabayashi, Mika Sasaki, Yohei Matoba, Tomoko Takahashi, Naomi Ogawa, Katsumi Mizuta, Sueshi Ito, Noriko Kishida, Kazuya Nakamura, Masayuki Shirakura, Shinji Watanabe, and Hideki Hasegawa
Author affiliation: Author affiliations: National Institute of Infectious Diseases, Tokyo, Japan (E. Takashita, H. Morita, S. Nagata, S. Fujisaki, H. Miura, N. Kishida, K. Nakamura, M. Shirakura, S. Watanabe, H. Hasegawa); Yamagata Prefectural Institute of Public Health, Yamagata, Japan (T. Ikeda, K. Komabayashi, M. Sasaki, Y. Matoba, T. Takahashi, N. Ogawa, K. Mizuta); Ito Clinic, Yamagata (S. Ito)

Main Article

Figure 1

Detection of influenza viruses in Yamagata, Japan, during the 2022–23 and 2023–24 influenza seasons (n = 619). Monthly reports of influenza virus detection by the National Epidemiologic Surveillance of Infectious Diseases (https://www.niid.go.jp/niid/en/survaillance-data-table-english.html) were used for study of influenza A(H1N1)pdm09 virus with reduced susceptibility to baloxavir. Clinical specimens were collected from outpatients who had influenza or influenza-like illness diagnosed.

Figure 1. Detection of influenza viruses in Yamagata, Japan, during the 2022–23 and 2023–24 influenza seasons (n = 619). Monthly reports of influenza virus detection by the National Epidemiologic Surveillance of Infectious Diseases (https://www.niid.go.jp/niid/en/survaillance-data-table-english.html) were used for study of influenza A(H1N1)pdm09 virus with reduced susceptibility to baloxavir. Clinical specimens were collected from outpatients who had influenza or influenza-like illness diagnosed.

Main Article

Page created: March 19, 2025
Page updated: April 03, 2025
Page reviewed: April 03, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external